PROGNOSTIC HETEROGENEITY AMONG HIGH RISK MULTIPLE MYELOMA PATIENTS (T(4-14) AND DEL17P) ACCORDING TO ADDITIONAL CYTOGENETIC ABNORMALITIES, THE IFM EXPERIENCE

被引：0
|
作者：
Benjamin, H. [1 ]
Florence, M. [2 ]
Alice, C. [3 ,4 ]
Valerie, L. C. [1 ]
Marie-Lorraine, C. [5 ]
Cyrille, H. [6 ]
Xavier, L. [7 ]
Gerald, M. [8 ]
Lionel, K. [9 ]
Murielle, R. [1 ]
Philippe, R. [10 ]
Catherine, S. [9 ]
Francois, L. [11 ]
Sabine, B. [12 ]
Marie, S. Anne [13 ]
Marc, W. [14 ]
Frederique, O. P. [15 ]
Sylvie, C. [16 ]
Gerard, L. [17 ]
Brrigitte, P. [18 ]
Karim, B. [19 ]
Jean, F. [20 ]
Laurent, V. [21 ]
Laurent, G. [22 ]
Bruno, R. [23 ]
Mamoun, D. [24 ]
Margaret, M. [25 ]
Denis, C. [26 ]
Mohamad, M. [22 ]
Thierry, F. [7 ]
Philippe, M. [27 ]
Michel, A. [28 ]
Jill, C. [29 ,30 ]
Stephane, M. [27 ]
Herve, A. L. [31 ,32 ]
机构：
[1] Hop Purpan, Toulouse, France
[2] UMR S 892, Nantes, France
[3] Hop Rangueil, Unite Genom Myelome, Toulouse, France
[4] Hop Rangueil, INSERM, U1037, CRCT, Toulouse, France
[5] Hop Dijon, Dijon, France
[6] Ctr Univ Nancy Brabois, Nancy, France
[7] CHRU Lille, F-59037 Lille, France
[8] Grp Hosp Haut Leveque, Bordeaux, France
[9] CHU Lyon, Lyon, France
[10] CH Perigueux, Perigueux, France
[11] CH DAX, Dax, France
[12] Hop Avicenne, Paris, France
[13] Inst J Paoli I Calmettes, F-13009 Marseille, France
[14] CH DUNKERQUE, Dunkerque, France
[15] CH Annecy, Annecy, France
[16] CH AIX, Aix En Provence, France
[17] CH AVIGNON, Avignon, France
[18] CH Grenoble, Grenoble, France
[19] AP HP, Paris, France
[20] CH Besancon, Besancon, France
[21] CH Chalon, Chalon Sur Saone, France
[22] CH St Antoine, Paris, France
[23] CH Amiens, Amiens, France
[24] CH Angers, Angers, France
[25] CH Caen, Caen, France
[26] CH DIJON, Dijon, France
[27] CHU Nantes, F-44035 Nantes 01, France
[28] Inst Claudius Regaud, Toulouse, France
[29] CHU Purpan, Unite Genom Myelome, Toulouse, France
[30] CHU Purpan, INSERM, U1037, CRCT, Toulouse, France
[31] CHU Toulouse, Unite Genom Myelome, Toulouse, France
[32] CHU Toulouse, INSERM, U1037, CRCT, Toulouse, France
来源：
HAEMATOLOGICA | 2014年 / 99卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S1287
引用
收藏
页码：495 / 495
页数：1
相关论文
共 47 条
  • [21] COMBINATION OF T(4;14), DEL(17P13), DEL(1P32) AND 1Q21 GAIN FISH PROBES IDENTIFIES CLONAL HETEROGENEITY AND ENHANCES DETECTION OF ADVERSE CYTOGENETIC PROFILES IN 233 NEWLY DIAGNOSED MULTIPLE MYELOMA
    Smol, T.
    Dufour, A.
    Tricot, S.
    Wemeau, M.
    Stalnikiewicz, L.
    Bernardi, F.
    Christine, T.
    Daudignon, A.
    HAEMATOLOGICA, 2016, 101 : 514 - 514
  • [22] Combination of t(4;14), del(17p13), del(1p32) and 1q21 gain FISH probes identifies clonal heterogeneity and enhances the detection of adverse cytogenetic profiles in 233 newly diagnosed multiple myeloma
    Thomas Smol
    Annika Dufour
    Sabine Tricot
    Mathieu Wemeau
    Laure Stalnikiewicz
    Franck Bernardi
    Christine Terré
    Benoît Ducourneau
    Hervé Bisiau
    Agnès Daudignon
    Molecular Cytogenetics, 10
  • [23] Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients
    Chretien, Marie-Lorraine
    Hebraud, Benjamin
    Cances-Lauwers, Valerie
    Hulin, Cyrille
    Marit, Gerald
    Leleu, Xavier
    Karlin, Lionel
    Roussel, Murielle
    Stoppa, Anne-Marie
    Guilhot, Francois
    Lamy, Thierry
    Garderet, Laurent
    Pegourie, Brigitte
    Dib, Mamoun
    Sebban, Catherine
    Lenain, Pascal
    Brechignac, Sabine
    Royer, Bruno
    Wetterwald, Marc
    Legros, Laurence
    Orsini-Piocelle, Frederique
    Voillat, Laurent
    Delbrel, Xavier
    Caillot, Denis
    Macro, Margaret
    Facon, Thierry
    Attal, Michel
    Moreau, Philippe
    Avet-Loiseau, Herve
    Corre, Jill
    HAEMATOLOGICA, 2014, 99 (07) : 1236 - 1238
  • [24] Survival Trends over 18 Years of Patients with Multiple Myeloma Harboring Del(17p) and/or t(4;14): A Retrospective Real-World Study
    Chalopin, Thomas
    Vallet, Nicolas
    Ochmann, Marlene
    Tiab, Mourad
    Godmer, Pascal
    Barin, Carole
    Theisen, Olivier
    Herault, Olivier
    Gyan, Emmanuel
    Benboubker, Lotfi
    Moreau, Philippe
    Avet-Loiseau, Herve
    Touzeau, Cyrille
    BLOOD, 2020, 136
  • [25] Survival analysis of transplant-eligible newly-diagnosed multiple myeloma patients harboring t(4;14), t(14;16), and/or del(17p) in the real-world setting
    Garrido, David
    Slavutsky, Irma
    Riva, Eloisa
    CURRENT PROBLEMS IN CANCER, 2023, 47 (01)
  • [26] Long-term follow-up of 100 de novo multiple myeloma patients with t(4;14) prospectively treated according to IFM99 protocols
    Moreau, P.
    Charbonnel, C.
    Attal, M.
    Garban, F.
    Hulin, C.
    Facon, T.
    Marit, G.
    Michallet, M.
    Doyen, C.
    Leyvraz, S.
    Mohty, M.
    Wetterwald, M.
    Mathiot, C.
    Caillot, D.
    Berthou, C.
    Garderet, L.
    Chaleteix, C.
    Traulle, C.
    Fuzibet, J. G.
    Jaubert, J.
    Lamy, T.
    Casassus, P.
    Dib, M.
    Kolb, B.
    Dorvaux, V.
    Grosbois, B.
    Yakoub-Agha, I.
    Harousseau, J. L.
    Avet-Loiseau, H.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S3 - S3
  • [27] MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis
    Lazareth, Anne
    Song, Xiu-Yi
    Coquin, Aurelie
    Harel, Stephanie
    Karlin, Lionel
    Belhadj, Karim
    Roos-Weil, Damien
    Frenzel, Laurent
    Tamburini, Jerome
    Macro, Margaret
    Chevret, Sylvie
    Avet-Loiseau, Herve
    Minvielle, Stephane
    Fermand, Jean Paul
    Soulier, Jean
    Bories, Jean Christophe
    Arnulf, Bertrand
    HAEMATOLOGICA, 2015, 100 (11) : E471 - E474
  • [28] Progression in Smoldering Myeloma Is Independently Determined by the Chromosomal Abnormalities del(17p), t(4;14), Gain 1q, Hyperdiploidy, and Tumor Load
    Neben, Kai
    Jauch, Anna
    Hielscher, Thomas
    Hillengass, Jens
    Lehners, Nicola
    Seckinger, Anja
    Granzow, Martin
    Raab, Marc S.
    Ho, Anthony D.
    Goldschmidt, Hartmut
    Hose, Dirk
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4325 - U59
  • [29] Upfront stem cell transplantation for newly diagnosed multiple myeloma with del(17p) and t(4;14): a study from the CMWP-EBMT
    Gagelmann, Nico
    Eikema, Diderik-Jan
    de Wreede, Liesbeth C.
    Rambaldi, Alessandro
    Iacobelli, Simona
    Koster, Linda
    Caillot, Denis
    Blaise, Didier
    Rememyi, Peter
    Bulabois, Claude-Eric
    Passweg, Jakob
    Leleu, Xavier
    Zver, Samo
    Kobbe, Guido
    Ljungman, Per
    Chevallier, Patrice
    Ringhoffer, Mark
    Martin, Murray
    Salmenniemi, Urpu
    Poire, Xavier
    Lenhoff, Stig
    Pioltelli, Pietro
    Mordini, Nicola
    Delforge, Michel
    Garderet, Laurent
    Schoenland, Stefan
    Yakoub-Agha, Ibrahim
    Kroeger, Nicolaus
    BONE MARROW TRANSPLANTATION, 2021, 56 (01) : 210 - 217
  • [30] POMALIDOMIDE PLUS LOW-DOSE DEXAMETHASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM) WITH DELETION DEL(17P) AND/OR TRANSLOCATION T(4;14)
    Leleu, X.
    Macro, M.
    Karlin, L.
    Hulin, C.
    Garderet, L.
    Roussel, M.
    Arnulf, B.
    Pegourie, B.
    Kolb, B.
    Stoppa, A. M.
    Brechiniac, S.
    Michallet, M.
    Marit, G.
    Mathiot, C.
    Banos, A.
    Lacotte, L.
    Dib, M.
    Fuzibet, J. G.
    Petillon, M. O.
    Rodon, P.
    Wetterwald, M.
    Royer, B.
    Legros, L.
    Benboubker, L.
    Decaux, O.
    Caillot, D.
    Escoffre-Barbe, M.
    Fermand, J. P.
    Moreau, P.
    Attal, M.
    Avet-Loiseau, H.
    Facon, T.
    HAEMATOLOGICA, 2014, 99 : 109 - 109
12345